当前位置: 首页 > 详情页

【已隐藏】Interleukin-1 beta Promotes Ox-LDL Uptake by Human Glomerular Mesangial Cells via LOX-1

本文已应作者要求隐藏

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Nephrology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China [2]Department of Geriatrics, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
出处:
ISSN:

关键词: Interleukin-1 beta oxidised low-density lipoprotein lectin-like Ox-LDL receptor 1

摘要:
The aim of this study was to determine whether interleukin-1 beta (IL-1 beta) promotes oxidised low-density lipoprotein (Ox-LDL) uptake by human glomerular mesangial cells (HMCs) and its effect on the expression of lectin-like Ox-LDL receptor 1 (LOX-1) and to identify pathways through which IL - 1 beta affects lipid uptake. Confocal laser scanning microscopy and flow cytometry were used to observe the effect of IL-1 beta on lipid uptake by HMCs and the pathway by which IL-1 beta may mediate lipid uptake. Real-time polymerase chain reaction (PCR) and western blotting were used to evaluate the effect of IL - 1 beta on LOX-1 expression. Confocal laser scanning microscopy and flow cytometry revealed that IL-1 beta promoted uptake of fluorescent Dil-labelled Ox-LDL(Dil-Ox-LDL) by HMCs and the enhanced uptake of Dil-Ox-LDL was partially inhibited by an anti-LOX-1 antibody evaluated by flow cytometry. Further, IL - 1 beta promoted LOX-1 mRNA and protein expression of HMCs in a dose- and time-dependent manner. Thus, Ox-LDL is ingested by HMCs under basic conditions. Inflammatory cytokine IL-1 beta promotes Ox-LDL uptake by HMCs. Furthermore, IL-1 beta promotes the mRNA and protein expression of LOX-1, a specific receptor of Ox-LDL, suggesting that the enhancement of Ox-LDL uptake may be mediated by LOX-1 pathway. Anti-LOX-1 therapy may be a promising option for treatment of glomerulosclerosis.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 3 区 医学
小类 | 3 区 医学:内科
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 医学:内科
JCR分区:
出版当年[2018]版:
Q2 MEDICINE, GENERAL & INTERNAL
最新[2023]版:
Q1 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Department of Nephrology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院